Richard L. Hayward

Increased Incidence of Visceral Metastases in Scottish Patients With BRCA1/2-Defective Ovarian Cancer: An Extension of the Ovarian BRCAness Phenotype

Charlie Gourley, Caroline O. Michie, Patricia Roxburgh et al. · Journal of Clinical Oncology · 2010 · 91 citations

Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect

Richard L. Hayward, Janet S. Macpherson, Jeff Cummings et al. · Molecular Cancer Therapeutics · 2004 · 88 citations · Full text

The identification of discrete prognostic groups in low grade non-Hodgkin's lymphoma

Robert Leonard, Richard L. Hayward, R.J. Prescott et al. · Annals of Oncology · 1991 · 81 citations

Lymphoid Neoplasia, Oncology, Discrete Prognostic Groups +8

Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175

Richard L. Hayward, Q. C. Schornagel, R. Tente et al. · Cancer Chemotherapy and Pharmacology · 2005 · 76 citations

Chemoprevention Strategy, Novel Cytotoxic Ruthenium, Oncogenic Agent +11

Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity.

Richard L. Hayward, Janet S. Macpherson, Jeff Cummings et al. · PubMed · 2003 · 68 citations